Brillia Health Cough Control by Hadaf LLC / Santonika Uab 72123-005 Cough Control

Brillia Health Cough Control by

Drug Labeling and Warnings

Brillia Health Cough Control by is a Homeopathic medication manufactured, distributed, or labeled by Hadaf LLC, Santonika Uab. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

BRILLIA HEALTH COUGH CONTROL- homeopathic tablet 
Hadaf LLC

Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

----------

72123-005 Cough Control

Active Ingredients

Lapine bradykinin immune globulin 12C, 30C, 50C Purpose Reduces frequency and intensity of cough
Lapine morphine immune globulin 12C, 30C, 50C Purpose Reduces pain response
Lapine histamine immune globulin 12C, 30C, 50C Purpose.Reduces histamine and inflammation response

Purpose

Homeopathic,
Reduces frequency and intensity of cough
Reduces pain responseLapine histamine immune
Reduces histamine and inflammation response

Uses

Suppresses wet and dry cough
Reduces severity and duration of symptoms, including nasal congestion, cough and sore/itchy throat
Antihistamine and decongestant/anti-inflammatory
Reduces sore throat pain

Warnings

Stop use and ask a doctor if symptoms persist or worsen.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Allergic (hypersensitivity) reactions may occur in very rare cases.
Do not use if known sensitivity to Brillia Health Cough Control or
any of its ingredients exists.

Stop use

Stop use and ask a doctor if symptoms persist or worsen.

Pregnancy

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Allergies

Allergic (hypersensitivity) reactions may occur in very rare cases.

Do Not Use

Do not use if known sensitivity to Brillia Health Cough Control or
any of its ingredients exists.

Directions

For adults and children 3 years and older.
Take orally by holding tablet in the mouth until completely dissolved, without food.
1 to 2 tablets 3 times daily.
For severe symptoms, take 4 to 6 times daily for the first 3 days.

Other Information

Store in original package below 25°C or 77°F.
Do not use if blister pack is torn or broken.

Inactive ingredients

Isomalt, Microcrystalline cellulose, Magnesium stearate, Citric acid (anhydrous), Aspartame, Sodium saccharin.

20 Tablets NDC: 72123-005-01

BRILLIA HEALTH COUGH CONTROL 
homeopathic tablet

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 72123-005
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
LAPINE MORPHINE IMMUNE GLOBULIN (UNII: OS064NQ92E) (LAPINE MORPHINE IMMUNE GLOBULIN - UNII:OS064NQ92E)	LAPINE MORPHINE IMMUNE GLOBULIN	12 [hp_C]  in 12 [hp_C]
LAPINE BRADYKININ IMMUNE GLOBULIN (UNII: FX59DZ02OS) (LAPINE BRADYKININ IMMUNE GLOBULIN - UNII:FX59DZ02OS)	LAPINE BRADYKININ IMMUNE GLOBULIN	12 [hp_C]  in 12 [hp_C]
LAPINE HISTAMINE IMMUNE GLOBULIN (UNII: 7U4T47R0DD) (LAPINE HISTAMINE IMMUNE GLOBULIN - UNII:7U4T47R0DD)	LAPINE HISTAMINE IMMUNE GLOBULIN	12 [hp_C]  in 12 [hp_C]

Inactive Ingredients
Ingredient Name	Strength
MAGNESIUM STEARATE (UNII: 70097M6I30)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
ISOMALT (UNII: S870P55O2W)
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
ASPARTAME (UNII: Z0H242BBR1)
SACCHARIN SODIUM (UNII: SB8ZUX40TY)

Product Characteristics
Color	white	Score	score with uneven pieces
Shape	ROUND	Size	9mm
Flavor		Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 72123-005-01	12 [hp_C] in 1 BLISTER PACK; Type 0: Not a Combination Product	07/31/2020

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved homeopathic		07/31/2020	08/07/2020

Labeler - Hadaf LLC (094114708)

Establishment
Name	Address	ID/FEI	Business Operations
Santonika Uab		520214047	manufacture(72123-005)

Revised: 1/2022

Document Id: d5e1da7d-5568-d48d-e053-2a95a90a2d1c

34390-5

Set id: abc7a32d-bea0-c99e-e053-2a95a90a62bf

Version: 3

Effective Time: 20220118